PubMed Health⌕ Search

Biomedical subjects

T K Duditskaia

Publications and source records attributed to T K Duditskaia.

4 recordsLinked to original sources

[The initial location of the tumor as a prognostic factor in chemodectomas of the neck].

Starting from 1979, chemodectomas of the neck are classified at Cancer Research Center as follows: carotid, from vagus nerve paraganglia, and atypical. A total of 135 patients with chemodectomas of the neck were observed, 84 of these with chemodectomas of the carotid body, 40 with tumors originating from vagus nerve ganglia, and 11 with atypical tumors. Analysis of clinical manifestations showed the absence of recurrences after surgery. Vagus nerve chemodectomas were associated with neurological symptoms because of tumor dissemination into the parapharyngeal space under the cranial vault; for this cause, surgical intervention was often not radical. Atypical chemodectomas were liable to stubborn relapsing, necessitating reoperations. Identification of the source of chemodectoma is the crucial prognostic factor for the patient.

Carotid Body↗

[Radioimmunologic analysis in the differential diagnosis of cancer of the thyroid gland].

Investigations using a radioimmunoassay in 92 patients with nodular goiter, thyroid adenoma and cancer have shown that changes in the levels of T4, T3 and TSH cannot be used in differential diagnosis of tumors. A high level of thyroglobulin (TG) in 70-75% of patients in the absence of antibodies to it and the presence of a "cold node" on a scan is suggestive of differentiated types of thyroid cancer. In these cases TG can serve as a tumor marker. A moderate level of Tg in 25-30% of cases against a background of a high level of antibodies to it does not permit its use as a tumor marker in such patients even in the postoperative period. High levels of TG and TSH despite the use of thyroid drugs in patients, operated on for differentiated types of thyroid cancer, may be suggestive of a possible manifestation of a recurrence or metastatic spreading.

Adenocarcinoma↗